Kodiak Sciences
KOD
91.08
-1.26
-1.36%
Kodiak Sciences
US · KOD
#1934 by market cap
Listed 2018
91.08
-1.26
-1.36%
Live - 5344 symbols - heartbeat 218s ago
· 2026-10-08 07:27
Pre-market
90.45
-0.69%
After-hours
91.08
0.00%
Overnight
90.38
-0.77%
- Market cap
- 5.72B
- P/E (TTM)i
- -21.74
- P/Bi
- 93.70
- EPSi
- -4.32
- Div yieldi
- 0.00%
- 52W posi
- 86%
Reader sentiment
Are you bullish or bearish on KOD?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 7 analysts
Buy
Avg price target
115.20 +26.5%
Price target rangecurrent 91.08
Low96.00
Avg115.20
High145.00
Buy 86%
Hold 14%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-05 | Jefferies | -- | BUY | 112.00 |
| 2026-09-29 | Goldman Sachs | -- | HOLD | 103.00 |
| 2026-09-29 | H.C. Wainwright | -- | BUY | 96.00 |
| 2026-09-28 | LifeSci Capital | -- | BUY | 145.00 |
| 2026-09-28 | UBS | -- | BUY | 120.00 |
| 2026-09-28 | Jefferies | -- | BUY | 112.00 |
| 2026-09-28 | Evercore | -- | BUY | -- |
| 2026-09-28 | H.C. Wainwright | -- | BUY | 96.00 |
| 2026-09-28 | J.P. Morgan | -- | BUY | -- |
| 2026-09-24 | Goldman Sachs | -- | HOLD | -- |
| 2026-09-17 | H.C. Wainwright | -- | BUY | 58.00 |
| 2026-09-01 | J.P. Morgan | -- | BUY | 69.00 |
| 2026-08-17 | H.C. Wainwright | -- | BUY | 58.00 |
| 2026-08-15 | LifeSci Capital | -- | BUY | 85.00 |
| 2026-08-14 | UBS | -- | BUY | 80.00 |
| 2026-08-13 | UBS | -- | BUY | 80.00 |
| 2026-08-11 | LifeSci Capital | -- | BUY | 65.00 |
| 2026-08-06 | LifeSci Capital | -- | BUY | 65.00 |
| 2026-08-03 | J.P. Morgan | -- | BUY | 66.00 |
| 2026-06-29 | LifeSci Capital | -- | BUY | 65.00 |
| 2026-05-13 | J.P. Morgan | -- | BUY | 56.00 |
| 2026-05-11 | H.C. Wainwright | -- | BUY | 58.00 |
| 2026-05-09 | LifeSci Capital | -- | BUY | 65.00 |
| 2026-05-08 | LifeSci Capital | -- | BUY | 65.00 |
| 2026-04-03 | J.P. Morgan | -- | BUY | 60.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Strong Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2023/Q4 | 2024-03-28 | -- | ±26.78% | -15.40% (in line) |
| 2020/Q3 | 2020-11-09 | -- | ±15.50% | +3.62% (in line) |
| 2020/Q1 | 2020-05-12 | After close | ±15.86% | -3.66% (in line) |
| 2019/Q3 | 2019-11-12 | -- | -- | -6.10% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:27:41 · For reference only, not investment advice and not tailored to your situation.